JP2021091684A - Plant extract composition and method for preparing the same - Google Patents
Plant extract composition and method for preparing the same Download PDFInfo
- Publication number
- JP2021091684A JP2021091684A JP2020202787A JP2020202787A JP2021091684A JP 2021091684 A JP2021091684 A JP 2021091684A JP 2020202787 A JP2020202787 A JP 2020202787A JP 2020202787 A JP2020202787 A JP 2020202787A JP 2021091684 A JP2021091684 A JP 2021091684A
- Authority
- JP
- Japan
- Prior art keywords
- plant
- composition
- plant extract
- extract
- extract composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 239000000419 plant extract Substances 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims abstract description 22
- 241000196324 Embryophyta Species 0.000 claims abstract description 42
- 239000000284 extract Substances 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 244000048199 Hibiscus mutabilis Species 0.000 claims abstract description 10
- 241000729173 Cirsium japonicum Species 0.000 claims abstract description 8
- 240000001899 Murraya exotica Species 0.000 claims abstract description 7
- 235000009696 Murraya paniculata Nutrition 0.000 claims abstract description 7
- 241000218218 Ficus <angiosperm> Species 0.000 claims abstract description 5
- 235000003973 Hibiscus mutabilis Nutrition 0.000 claims abstract description 5
- 235000008766 Murraya exotica Nutrition 0.000 claims abstract description 5
- 244000075440 Catunaregam spinosa Species 0.000 claims abstract description 3
- 241000037797 Coptis quinquefolia Species 0.000 claims abstract description 3
- 241000361621 Ficus formosana Species 0.000 claims abstract description 3
- 241000178321 Glycine tomentella Species 0.000 claims abstract description 3
- 241000904340 Ventilago elegans Species 0.000 claims abstract description 3
- 238000010438 heat treatment Methods 0.000 claims description 9
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 6
- 238000004255 ion exchange chromatography Methods 0.000 claims description 6
- 240000002373 Ficus pumila Species 0.000 claims description 4
- 235000006718 Ficus pumila Nutrition 0.000 claims description 4
- 240000006859 Jasminum officinale Species 0.000 claims description 3
- 235000010254 Jasminum officinale Nutrition 0.000 claims description 3
- 241000219094 Vitaceae Species 0.000 claims description 3
- 235000021021 grapes Nutrition 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 229940069765 bean extract Drugs 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 229940038487 grape extract Drugs 0.000 claims description 2
- 241000218202 Coptis Species 0.000 claims 2
- 241000776115 Ampelopsis glandulosa var. brevipedunculata Species 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 15
- 239000004480 active ingredient Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 5
- 244000247747 Coptis groenlandica Species 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 231100000167 toxic agent Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 241000933771 Ficus erecta Species 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000000222 aromatherapy Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229940107700 pyruvic acid Drugs 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- -1 crown ether-5 Chemical compound 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- RXJKFRMDXUJTEX-UHFFFAOYSA-N triethylphosphine Chemical compound CCP(CC)CC RXJKFRMDXUJTEX-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明の目的は、抽出組成物およびその調製方法を提供することであり、具体的には、植物抽出物組成物およびその調製方法に関する。 An object of the present invention is to provide an extraction composition and a method for preparing the same, and specifically, the present invention relates to a plant extract composition and a method for preparing the same.
近年、自然への回帰を求める声が高まる中、植物抽出物への注目が高まっている。植物抽出物の定義は、世界中の国で完全に同じではないが、一般的には、植物を原料として使用し、抽出された最終製品の使用方法と使用方法に従って、物理的および化学的抽出および分離プロセスを通じて、植物内の1つ以上の有効成分を取得、濃縮することである。 In recent years, as calls for a return to nature have increased, attention has been focused on plant extracts. The definition of plant extracts is not exactly the same in countries around the world, but in general, plants are used as raw materials and physically and chemically extracted according to the usage and usage of the final product extracted. And through the separation process, one or more active ingredients in the plant are obtained and concentrated.
アロマセラピーとは、アロマ植物から抽出したエッセンシャルオイルを媒体とし、マッサージ、入浴、お香などによって気道や皮膚から体内に吸収され、精神的ストレスを和らげ、健康状態を改善する自然療法である。アロマテラピーは古代エジプトで始まり、現代ヨーロッパで人気が出てきたが、主流の医学では認められていない代替医療である。 Aromatherapy is a natural remedy that uses essential oils extracted from aroma plants as a medium and is absorbed into the body through the respiratory tract and skin by massage, bathing, incense, etc. to relieve mental stress and improve health. Aromatherapy is an alternative medicine that began in ancient Egypt and has become popular in modern Europe, but is not recognized in mainstream medicine.
植物蒸気浴とは、植物抽出物の燃焼によって生成される煙または植物抽出物の沸騰によって生成される蒸気を使用して、植物抽出物の有効成分を皮膚の毛穴や経穴に入れ、内臓に浸透させ、直接吸収により有効成分を全身に移して効果を出す方法である。蒸気浴は、皮膚に加温効果をもたらし、植物抽出物の有効成分を促進して皮膚に均一に接触し、細胞の透過性を高めるため、熱因子と霧状の有効成分が皮膚表面に吸収され、ケラチンに浸透し、真皮層で輸送され、最終的に血液循環に入り、皮膚温度を上昇させて毛細血管を拡張し、血液とリンパ循環を促進し、心臓への負担を軽減し、代謝を促進するため、植物抽出物のエッセンスの浸透効果が大幅に向上する。植物蒸気浴は、調和の取れていない臓器機能を有益に調節し、人の気分を緩和し、筋肉をリラックスさせ、それによって睡眠を改善して、生理、心理のバランスを実現するだけでなく、血液を浄化して血液粘度を減らし、血管の弾力性の増加、病気の予防、顔色の改善、血液循環障害による疲労とめまいの緩和、経絡疾患の調整など効果を実現できる。 A plant steam bath uses the smoke produced by burning the plant extract or the steam produced by the boiling of the plant extract to put the active ingredients of the plant extract into the pores and warps of the skin and penetrate the internal organs. It is a method in which the active ingredient is transferred to the whole body by direct absorption to produce an effect. The steam bath has a warming effect on the skin, promotes the active ingredient of the plant extract, makes uniform contact with the skin, and enhances the permeability of cells, so that the heat factor and the atomized active ingredient are absorbed by the skin surface. It penetrates into keratin, is transported in the dermis layer, and finally enters the blood circulation, raises the skin temperature and dilates the capillaries, promotes blood and lymph circulation, reduces the burden on the heart, and metabolizes. The penetration effect of the essence of the plant extract is greatly improved. The plant steam bath not only beneficially regulates unbalanced organ function, relaxes one's mood, relaxes muscles, thereby improving sleep and achieving a balance of physiology and psychology. It purifies blood and reduces blood viscosity, increases the elasticity of blood vessels, prevents illness, improves complexion, relieves fatigue and dizziness due to impaired blood circulation, and regulates meridian diseases.
本発明の目的は、調製された植物抽出物組成物を植物蒸気浴と組み合わせて、最良の効果を達成することである。 An object of the present invention is to combine the prepared plant extract composition with a plant vapor bath to achieve the best effect.
上記の目的を達成するために、本出願は、植物抽出物組成物およびその調製方法を提供する。植物抽出物組成物は、使用者の湿気の除去および解毒することにより、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 To achieve the above object, the present application provides a plant extract composition and a method for preparing the same. The plant extract composition can achieve the effects of promoting metabolism, regulating physical strength, reducing inflammatory symptoms and promoting wound healing by removing and detoxifying the user's moisture.
本発明の目的は、植物抽出物組成物の調製方法を提供することである。その方法は:ノアザミ(Cirsium japonicum)、ヒロハヤブマメ(Glycine tomentella)、ゲッキツ(Murraya paniculata)、カザナビキ(Ventilago elegans)、フヨウ(Hibiscus mutabilis)、バイカオウレン(Coptis quinquefolia Miq.)、タイワンイヌビワ(Ficus formosana Maxim)、ハリザクロ(Catunaregam spinosa)、オオイタビ(Ficus pumil)およびキレハノブドウ(Ampelopsis brevipedunculata)を含む植物組成物を提供するステップと、前記植物組成物を水に浸すステップと、前記植物組成物を第1の溶液に浸すステップと、前記植物組成物と水を一緒に加熱して植物抽出物組成物を得るステップとを含む。 An object of the present invention is to provide a method for preparing a plant extract composition. The method: (. Coptis quinquefolia Miq) Noazami (Cirsium japonicum), Hirohayabumame (Glycine tomentella), Murraya paniculata (Murraya paniculata), Kazanabiki (Ventilago elegans), mutabilis (Hibiscus mutabilis), Baikaouren, Taiwan Ficus (Ficus formosana Maxim), A step of providing a plant composition containing Coptis quinque (Catunaregam spinosa), a citis quinque (Ficus plumil) and a citris quinque (Ampelopsis brevipedunculata), a step of immersing the plant composition in water, and a step of immersing the plant composition in a first solution. The step includes a step of heating the plant composition and water together to obtain a plant extract composition.
より好ましくは、前記植物抽出物組成物の調製方法は、植物抽出物組成物を40〜50度の湿度下で室温まで冷却し、残留物を取り除くステップを更に含む。 More preferably, the method for preparing the plant extract composition further comprises the step of cooling the plant extract composition to room temperature under a humidity of 40 to 50 degrees Celsius to remove residues.
より好ましくは、前記水と一緒に加熱するステップは、弱火で5時間加熱することを含む。 More preferably, the step of heating with the water comprises heating on low heat for 5 hours.
より好ましくは、前記第1の溶液は、水および酢を含み、且つpH値は7.2〜7.8の間にある。 More preferably, the first solution contains water and vinegar and has a pH value between 7.2 and 7.8.
より好ましくは、前記植物組成物の中にノアザミの割合は8.0〜12.0wt.%、ヒロハヤブマメの割合は10.0〜14.0wt.%、ゲッキツの割合は10.0〜14.0wt.%、カザナビキの割合は10.0〜14.0wt.%、フヨウの割合は8.0〜12.0wt.%、バイカオウレンの割合は8.0〜12.0wt.%、タイワンイヌビワの割合は6.0〜10.0wt.%、ハリザクロの割合は7.0〜11.0wt.%、オオイタビの割合は6.0〜10.0wt.%、そしてキレハノブドウの割合は7.0〜11.0wt.%である。 More preferably, the ratio of Cirsium japonicum in the plant composition is 8.0 to 12.0 wt. %, The proportion of Hirohaya bean is 10.0 to 14.0 wt. %, The ratio of jessamine is 10.0 to 14.0 wt. %, The ratio of Kazanaviki is 10.0 to 14.0 wt. %, The ratio of Fuyo is 8.0 to 12.0 wt. %, The ratio of coptis quinque is 8.0 to 12.0 wt. %, The ratio of Taiwan Inubiwa is 6.0 to 10.0 wt. %, The ratio of Harizakuro is 7.0 to 11.0 wt. %, The ratio of Climbing fig is 6.0 to 10.0 wt. %, And the proportion of Kirehano grapes is 7.0-11.0 wt. %.
本発明のもう一つの目的は、ノアザミ抽出物、ヒロハヤブマメ抽出物、ゲッキツ抽出物、カザナビキ抽出物、フヨウ抽出物、バイカオウレン抽出物、タイワンイヌビワ抽出物、ハリザクロ抽出物、オオイタビ抽出物およびキレハノブドウ抽出物を含む植物抽出物組成物を提供することである。 Another object of the present invention is to obtain Noazami extract, Hirohayabu bean extract, Gekitsu extract, Kazanabiki extract, Fuyo extract, Baikaouren extract, Taiwan Inubiwa extract, Harizakuro extract, Oitabi extract and Kirehano grape extract. To provide a plant extract composition comprising.
より好ましくは、前記植物抽出物組成物の総イオンクロマトグラフィー(TIC)プロファイルは、2.167±0.5分、2.662±0.5分、4.203±0.5分、78.23±0.5分、79.033±0.5分、79.792±0.5分、および82.327±0.5分にピークがある。 More preferably, the total ion chromatography (TIC) profile of the plant extract composition is 2.167 ± 0.5 minutes, 2.662 ± 0.5 minutes, 4.203 ± 0.5 minutes, 78. There are peaks at 23 ± 0.5 minutes, 79.033 ± 0.5 minutes, 79.792 ± 0.5 minutes, and 82.327 ± 0.5 minutes.
より好ましくは、前記植物抽出物組成物は、図3に示される総イオンクロマトグラフィーを有する。 More preferably, the plant extract composition has total ion chromatography as shown in FIG.
より好ましくは、前記植物抽出物組成物は、植物蒸気浴用の植物抽出物組成物である。 More preferably, the plant extract composition is a plant extract composition for a plant steam bath.
上記の植物抽出物組成物を植物蒸気浴の入浴剤の形で使用すると、使用者の湿気の除去および解毒するのを助けるため、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 When the above plant extract composition is used in the form of a plant vapor bath bath salt, it helps to remove moisture and detoxify the user, thus promoting metabolism, regulating physical fitness, reducing inflammatory symptoms and healing wounds. The effect of promotion can be achieved.
添付の図面を参照した以下の詳細な説明は、当分野の技術者にとってより明白にするであろう。そのうち:
以下、植物抽出物組成物の調製方法の実施例について、図面を参照しながら説明するが、理解を容易にするため、以下の実施例において同一の要素には同一の符号を付している。 Hereinafter, examples of the method for preparing the plant extract composition will be described with reference to the drawings, but for ease of understanding, the same elements are designated by the same reference numerals in the following examples.
本明細書に記載される任意の数値範囲は、同じ数値精度の範囲内のすべての部分範囲を包含することが意図されている。たとえば、範囲「1.0〜10.0」は、最小値1.0と最大値10.0、および最小値1.0と最大値10.0の間のすべてのサブ範囲(つまり、最小値が1.0以上、最大値が10.0以下)を含むことを目的としている。たとえば、1.1〜8.6。本明細書に記載されている最大数の限界は、その中のすべてのより低い数値の限界を包含することを意図し、本明細書に記載されているすべての最小の数の限界は、その中のすべてのより高い数値の限界を包含することが意図されている。 Any numerical range described herein is intended to cover all subranges within the same numerical accuracy range. For example, the range "1.0 to 10.0" is all subranges between the minimum value 1.0 and the maximum value 10.0, and the minimum value 1.0 and the maximum value 10.0 (that is, the minimum value value). Is 1.0 or more and the maximum value is 10.0 or less). For example, 1.1 to 8.6. The maximum number limits described herein are intended to include all lower numerical limits therein, and all minimum number limits described herein are said to be such. It is intended to include the limits of all the higher numbers in.
本明細書で「約」と記載されている特定の値は、測定誤差による特定の値の±10%、好ましくは±5%、より好ましくは±1%、さらにより好ましくは±0.1%の差をカバーすると理解することができる。 The specific value described herein as "about" is ± 10%, preferably ± 5%, more preferably ± 1%, even more preferably ± 0.1% of the specific value due to measurement error. It can be understood that it covers the difference between.
本明細書において、「室温」とは、約20〜35℃の温度をいう。 As used herein, the term "room temperature" refers to a temperature of about 20 to 35 ° C.
本明細書において、「小火」とは、漢方薬の煎じ薬に用いられる火の一種であり、「ゆっくり火」とも呼ばれ、通常、ゆっくりと温度が上がり、水がゆっくりと蒸発する加熱方法をいう。約80〜150℃の加熱を指す。 In the present specification, "small fire" is a kind of fire used for decoction of Chinese herbs, and is also called "slow fire", and usually refers to a heating method in which the temperature rises slowly and water evaporates slowly. .. Refers to heating at about 80-150 ° C.
本明細書において、「植物蒸気浴」とは、溶液を加熱して、気体に気化させてから吸収させる投与方法を指す。 As used herein, the term "vegetable vapor bath" refers to an administration method in which a solution is heated, vaporized into a gas, and then absorbed.
図1は、本願実施例による植物抽出物組成物の調製方法10の概略的フローチャートである。図1に示されるように、植物抽出物組成物を調製するための方法10は、植物組成物を提供するステップS101と、植物組成物を水に浸すステップS103と、植物組成物を第1の溶液に浸すステップS015と、植物組成物と水を一緒に加熱して植物抽出物組成物を得るステップS107とを含む。
FIG. 1 is a schematic flowchart of a
ステップS101において、ノアザミ、ヒロハヤブマメ、ゲッキツ、カザナビキ、フヨウ、バイカオウレン、タイワンイヌビワ、ハリザクロ、オオイタビおよびキレハノブドウを収集して洗って、本発明の植物組成物を提供する。一実施例により、流水で上記の材料を洗って、その表面にある土および不純物を除去し、より好ましくは、1分間4リトルの流量で上記材料を洗浄する。 In step S101, Cirsium japonicum, Orange jessamine, Orange jessamine, Confederate rose, Coptis quinque, Ficus erecta, Climbing fig, and Climbing fig are collected and washed to provide the plant composition of the present invention. According to one embodiment, the material is washed with running water to remove soil and impurities on its surface, more preferably at a flow rate of 4 little per minute.
一実施例により、その植物組成物の中に、ノアザミの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、ヒロハヤブマメの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、ゲッキツの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、カザナビキの割合は10.0〜14.0wt.%、より好ましくは11.0〜13.0wt.%、更に好ましくは12.0wt.%であり、フヨウの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、バイカオウレンの割合は8.0〜12.0wt.%、より好ましくは9.0〜11.0wt.%、更に好ましくは10.0wt.%であり、タイワンイヌビワの割合は6.0〜10.0wt.%、より好ましくは7.0〜9.0wt.%、更に好ましくは8.0wt.%であり、ハリザクロの割合は7.0〜11.0wt.%、より好ましくは8.0〜10.0wt.%、更に好ましくは9.0wt.%であり、オオイタビの割合は6.0〜10.0wt.%、より好ましくは7.0〜9.0wt.%、更に好ましくは8.0wt.%であり、そしてキレハノブドウの割合は7.0〜11.0wt.%、より好ましくは8.0〜10.0wt.%、更に好ましくは9.0wt.%である。しかし、本発明はこれに限定されない。 According to one example, the proportion of Cirsium japonicum in the plant composition is 8.0-12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the proportion of hirohayabume is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of jessamine is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of Kazanaviki is 10.0 to 14.0 wt. %, More preferably 11.0 to 13.0 wt. %, More preferably 12.0 wt. %, And the proportion of Fuyo is 8.0 to 12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the proportion of coptis quinque is 8.0 to 12.0 wt. %, More preferably 9.0 to 11.0 wt. %, More preferably 10.0 wt. %, And the ratio of Taiwan Ficus erecta is 6.0 to 10.0 wt. %, More preferably 7.0-9.0 wt. %, More preferably 8.0 wt. %, And the proportion of Hari pomegranate is 7.0 to 11.0 wt. %, More preferably 8.0 to 10.0 wt. %, More preferably 9.0 wt. %, And the proportion of figs is 6.0 to 10.0 wt. %, More preferably 7.0-9.0 wt. %, More preferably 8.0 wt. %, And the proportion of Kirehano grapes is 7.0-11.0 wt. %, More preferably 8.0 to 10.0 wt. %, More preferably 9.0 wt. %. However, the present invention is not limited to this.
ステップS103において、上記ステップS101が提供した植物組成物を水に浸して水溶性有毒物を更に除去し、そして、水溶性有毒物が除去された植物組成物をステップS105の浸すを実行する。 In step S103, the plant composition provided in step S101 is immersed in water to further remove the water-soluble toxic substance, and the plant composition from which the water-soluble toxic substance has been removed is immersed in step S105.
ステップS105において、水溶性有毒物が除去された植物組成物を第1の溶液に浸して軟化させることにより、後の工程で植物組成物中の有効成分を抽出しやすくなる。使用する第1の溶液のpH値は約7.2〜7.8で、酢と純水が含まれている。ステップS105における浸漬時間は、約20〜30時間、好ましくは22〜28時間、より好ましくは24時間とすることができる。 In step S105, by immersing the plant composition from which the water-soluble toxic substance has been removed in the first solution to soften it, the active ingredient in the plant composition can be easily extracted in a later step. The first solution used has a pH value of about 7.2-7.8 and contains vinegar and pure water. The immersion time in step S105 can be about 20 to 30 hours, preferably 22 to 28 hours, more preferably 24 hours.
最後に、ステップS107において、浸漬および軟化された植物組成物および水を、約2〜6時間、好ましくは3〜5時間、より好ましくは5時間、小火で加熱して、本発明の植物抽出物組成物を得る。 Finally, in step S107, the soaked and softened plant composition and water are heated on a small fire for about 2-6 hours, preferably 3-5 hours, more preferably 5 hours to extract the plants of the present invention. Obtain the composition.
一実施例において、本発明の植物抽出物組成物は、40〜50度の湿度下で室温まで冷却され、その後、残留物を取り除いて保管することができ、セラミックまたはガラス材料の容器に保管するのがよい。上記の方法に従って得られた本発明の植物抽出物組成物は、図2に示すように、黄褐色の液体である。図2は、本発明の実施例による植物抽出物組成物の外観の写真である。 In one example, the plant extract composition of the present invention is cooled to room temperature under a humidity of 40-50 ° C., after which the residue can be removed and stored and stored in a container of ceramic or glass material. Is good. The plant extract composition of the present invention obtained according to the above method is a yellowish brown liquid as shown in FIG. FIG. 2 is a photograph of the appearance of the plant extract composition according to the embodiment of the present invention.
上記の方法に従って得られた本発明の植物抽出物組成物を、Agilent 7890BガスクロマトグラフおよびAgilent 5977A質量分析計により、以下のパラメーターでGC/MS分析を実行する:注入量:1μl;注入温度:280°C;キャリアガス:He;カラム:DB−5MS30m*0.25mm*0.25μm;カラム流量:1.0mL/min;イオン源温度(MSソース温度):230℃;クワッド温度(MAクワッド温度):150℃;MSスキャン範囲:40m/z〜550m/z;そして、GCオーブン加熱プログラムを以下の表1に示す。
高濃度の標準液として、0.01gのメンソールを使用して、メタノールを10mL(濃度1000μg/mL)まで定量する。10μLの高濃度標準溶液を使用して、低濃度標準溶液としてメタノール(濃度10μg/mL)で1mLに定量化する。そして、分析のために、本発明の実施例の植物抽出物組成物1.0232gを10mLに定量化する。得られた結果は、100ppmメンソールの面積値でのピーク値に対する相対定量を実行し、相対定量のパーセンテージを取得できる。結果を図3に示す。
Methanol is quantified to 10 mL (concentration 1000 μg / mL) using 0.01 g menthol as a high concentration standard solution. Quantify to 1 mL with methanol (
図3は、SGS HPLC質量分析後に得られた、本発明の実施例の植物抽出物組成の全イオンクロマトグラフィー(TIC)スペクトルである。図3からわかるように、本発明の実施例の植物抽出物組成には、2.167±0.5分、2.662±0.5分、4.203±0.5分、78.23±0.5分、79.033±0.5分、79.792±0.5分、82.327±0.5分にピーク値がある。 FIG. 3 is a total ion chromatography (TIC) spectrum of the plant extract composition of the examples of the present invention obtained after SGS HPLC mass spectrometry. As can be seen from FIG. 3, the plant extract composition of the examples of the present invention includes 2.167 ± 0.5 minutes, 2.662 ± 0.5 minutes, 4.203 ± 0.5 minutes, 78.23. There are peak values at ± 0.5 minutes, 79.033 ± 0.5 minutes, 79.792 ± 0.5 minutes, and 82.327 ± 0.5 minutes.
図3からわかるように、新しく合成された分子化合物は、自然界の植物で10種類を超える触媒イオン化を使用して得られた本発明の実施例の植物抽出物組成物に含まれている。次の表2〜4は、SGS HPLC質量分析後に得られた本発明の実施例の植物抽出物組成の成分の一部を示す。
上記の表2〜4から、本発明の実施例の植物抽出物組成物は、3−ヒドロキシブタノン、クラウンエーテル−5、ピルビン酸、メトキシエチルアミン、トリエチルホスフィン、バリン酸、シクロペンタジオン、2−ヒドロキシ−2−シクロペンテン−1−オン、ステアリン酸、およびアルコールを含む。その中、Crown−5(クラウン−5)は、水分を吸収しやすく、水と混和しやすいという特徴があり、カリウム/ナトリウムイオンに対する選択的な錯化力が強く、細胞膜に出入りできる効率的な相間移動触媒としての効果を持っている。したがって、本実施形態の植物抽出物組成物中の他の有効成分を効果的に人体の循環に取り込むことができ、吸収を促進して所望の効果を向上させることができる。ピルビン酸は、体内の酸素フリーラジカルの酸化を抑制し、フリーラジカルの損傷を防ぐ効果があり、心臓の再灌流障害や急性腎不全の際の機能的損傷から体を保護する効果がある。バリンは必須アミノ酸であり、筋肉の代謝を促進し、筋肉の協調を改善し、脳力を促進し、気分を安定させ、創傷治癒の治療を加速することができる。ステアリン酸は酸化を防止することができる。 From Tables 2-4 above, the plant extract compositions of the examples of the present invention are 3-hydroxybutanone, crown ether-5, pyruvic acid, methoxyethylamine, triethylphosphine, valine acid, cyclopentadione, 2-hydroxy. Includes -2-cyclopentene-1-one, stearic acid, and alcohol. Among them, Crown-5 has the characteristics that it easily absorbs water and is easily mixed with water, has a strong selective complexing power for potassium / sodium ions, and is efficient in entering and exiting the cell membrane. It has an effect as a phase transfer catalyst. Therefore, other active ingredients in the plant extract composition of the present embodiment can be effectively incorporated into the circulation of the human body, and absorption can be promoted to improve the desired effect. Pyruvic acid has the effect of suppressing the oxidation of oxygen free radicals in the body, preventing damage to free radicals, and protecting the body from functional damage during cardiac reperfusion injury and acute renal failure. Valine is an essential amino acid that can promote muscle metabolism, improve muscle coordination, promote brain strength, stabilize mood and accelerate wound healing treatment. Stearic acid can prevent oxidation.
本発明の実施例の植物抽出物組成物に含まれる成分によれば、本発明の実施例の植物抽出物組成物が植物蒸気浴により使用される場合、使用者の湿気の除去および解毒するのを助けるため、代謝の促進、体力の調節、炎症症状の軽減および創傷治癒の促進の効果を達成できる。 According to the components contained in the botanical extract composition of the examples of the present invention, when the botanical extract composition of the examples of the present invention is used by a plant steam bath, it removes moisture and detoxifies the user. It can achieve the effects of promoting metabolism, regulating physical strength, reducing inflammatory symptoms and promoting wound healing.
図4および図5は、使用者がこの場合の実施形態の植物抽出物組成物を植物蒸気浴の形で使用した後の効果図である。図4のパート(a)は、使用者が本発明の実施例の植物抽出物組成物をまだ使用していない状況を示している。図4のパート(b)から(f)は、植物蒸気浴により実施例の植物抽出物組成物を使用した時間の長さを順に示している。図4のパート(b)は、使用者が本発明の実施例の植物抽出物組成物を最短時間で使用したことを示している。図4のパート(f)は、使用者が本発明の実施例の植物抽出物組成物を最も長い時間使用していることを示している。図4から、この実施例の植物抽出物組成物の解毒および除湿効果により、使用者の創傷治癒が加速されることが明確に分かる。図5のパート(a)は、使用者が本発明の実施例の植物抽出物組成物をまだ使用していない状況を示している。図5のパート(b)は、使用者が植物蒸気浴の形で本発明の実施例の植物抽出物組成物を使用した後の結果を示している。図5から、植物蒸気浴の形でこの実施例の植物抽出物組成物を使用すると、浮腫および除湿を除去する効果があることが明らかに分かる。 4 and 5 are effect diagrams after the user uses the plant extract composition of the embodiment in this case in the form of a plant vapor bath. Part (a) of FIG. 4 shows a situation in which the user has not yet used the plant extract composition of the embodiment of the present invention. Parts (b) to (f) of FIG. 4 show in order the length of time that the plant extract composition of the example was used in the plant steam bath. Part (b) of FIG. 4 shows that the user used the plant extract composition of the embodiment of the present invention in the shortest time. Part (f) of FIG. 4 shows that the user has been using the plant extract composition of the examples of the present invention for the longest time. From FIG. 4, it is clearly seen that the detoxifying and dehumidifying effects of the plant extract composition of this example accelerate the wound healing of the user. Part (a) of FIG. 5 shows a situation in which the user has not yet used the plant extract composition of the embodiment of the present invention. Part (b) of FIG. 5 shows the results after the user has used the plant extract composition of the examples of the present invention in the form of a plant vapor bath. From FIG. 5, it is clear that the use of the plant extract composition of this example in the form of a plant steam bath has the effect of removing edema and dehumidification.
上記の説明は単なる例示であり、限定的なものではない。本発明の範囲及び趣旨を逸脱することなく均等範囲内における変更及び修正は、いずれも添付の特許請求の範囲で扱うものとする。 The above description is merely an example and is not limiting. Any changes or amendments within the equivalent scope without departing from the scope and gist of the present invention shall be dealt with within the scope of the appended claims.
10…植物抽出物組成物の調製方法
S101〜S107…ステップ
10 ... Method for preparing plant extract composition S101-S107 ... Step
Claims (9)
The plant extract composition according to claim 6, wherein the plant extract composition is a plant extract composition for a plant steam bath.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW108145157 | 2019-12-10 | ||
TW108145157A TW202122102A (en) | 2019-12-10 | 2019-12-10 | Plant extracts and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2021091684A true JP2021091684A (en) | 2021-06-17 |
Family
ID=75962640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020202787A Pending JP2021091684A (en) | 2019-12-10 | 2020-12-07 | Plant extract composition and method for preparing the same |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2021091684A (en) |
CN (1) | CN112933148A (en) |
DE (1) | DE102020127448A1 (en) |
TW (1) | TW202122102A (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102106422B (en) * | 2009-12-23 | 2012-12-19 | 海南大学 | Method for preparing murraya paniculata tea |
CN102274288B (en) * | 2010-06-09 | 2013-07-17 | 台湾糖业股份有限公司 | Application of ficus formosana maxim extract as drug for preventing skin aging |
CN103393953B (en) * | 2013-08-18 | 2014-12-24 | 郝学江 | Traditional Chinese medicine ointment for promoting postoperative wound healing, and preparation method thereof |
-
2019
- 2019-12-10 TW TW108145157A patent/TW202122102A/en unknown
-
2020
- 2020-07-09 CN CN202010656155.6A patent/CN112933148A/en active Pending
- 2020-10-19 DE DE102020127448.3A patent/DE102020127448A1/en not_active Withdrawn
- 2020-12-07 JP JP2020202787A patent/JP2021091684A/en active Pending
Non-Patent Citations (12)
Title |
---|
HUANG, G. J. ET AL.: "Bioassay guided isolation and identification of anti-inflammatory active compounds from the root of", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 61, no. 46, JPN6021048060, 2013, pages 11008 - 11015, ISSN: 0004806002 * |
IKUTA AKIRA, ITOKAWA HIDEJI: "Protoberberine Alkaloids from Coptis quinqnefolia", 生薬学雑誌, vol. 第43巻, 第1号, JPN6021048061, 1989, pages 81 - 82, ISSN: 0004806001 * |
LAI, W. C. ET AL.: "Bioactive constituents of Cirsium japonicum var. australe", JOURNAL OF NATURAL PRODUCTS, vol. 77, no. 7, JPN6021048067, 2014, pages 1624 - 1631, XP055884475, ISSN: 0004805996, DOI: 10.1021/np500233t * |
LE, M. Q. ET AL.: "The Water-extracted Ampelopsis brevipedunculata downregulates IL-1β,CCL5, and COX-2 expression via", JOURNAL OF PHARMACOLOGICAL SCIENCES, vol. 126, no. 4, JPN6021048052, 2014, pages 359 - 369, ISSN: 0004806005 * |
LIAO, C. R. ET AL.: "Analgesic and Anti-Inflammatory Activities of Methanol Extract of Ficus pumila L. in Mice", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, vol. 2012, JPN6021048053, 2012, pages 340141 - 9, ISSN: 0004806004 * |
LIN, C. C. ET AL.: "Hepatoprotective effects of emodin from Ventilago leiocarpa", JOURNAL OF ETHNOPHARMACOLOGY, vol. 52, no. 2, JPN6021048063, 1996, pages 107 - 111, ISSN: 0004805999 * |
LU, T. C. ET AL.: "Analgesic and anti-inflammatory activities of aqueous extract from Glycine tomentella root in mice", JOURNAL OF ETHNOPHARMACOLOGY, vol. 113, no. 1, JPN6021048066, 2007, pages 142 - 148, XP022162828, ISSN: 0004805997, DOI: 10.1016/j.jep.2007.05.024 * |
MD. RAHMAN, A. ET AL.: "Antidiarrhoeal and Anti-Inflammatory Activities of Murraya Paniculata (L.) Jack", PHARMACOLOGYONLINE, vol. 3, JPN6021048065, pages 768 - 776, ISSN: 0004805998 * |
SAINI, H. ET AL.: "Anti-Inflammatory, Analgesic and Antipyretic Activity of Catunaregam spinosa (Thumb.) Tirveng Extrac", JOURNAL OF DRUG DELIVERY AND THERAPEUTICS, vol. 9, no. 5, JPN6021048057, September 2019 (2019-09-01), pages 89 - 94, ISSN: 0004806003 * |
WANG, J. ET AL.: "In vitro anti-inflammatory mechanism of Folium Hibisci Mutabilis leaves ethanol extracts", AFRICAN JOURNAL OF TRADITIONAL, COMPLEMENTARY, AND ALTERNATIVE MEDICINES, vol. 11, no. 1, JPN6021048062, 2013, pages 127 - 130, ISSN: 0004806000 * |
張 建雄 ほか: "台湾産生薬「黄金桂」の生薬学的研究", 生薬学雑誌, vol. 第47巻, 第4号, JPN6021048050, 1993, pages 377 - 387, ISSN: 0004806006 * |
編集代表 津田 恭介・野上 寿, 医薬品開発基礎講座 XI 薬剤製造法(上), JPN6020013236, 10 July 1971 (1971-07-10), pages 1 - 25, ISSN: 0004806007 * |
Also Published As
Publication number | Publication date |
---|---|
DE102020127448A1 (en) | 2021-06-10 |
CN112933148A (en) | 2021-06-11 |
TW202122102A (en) | 2021-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102397182B (en) | Compound essential oil for improving skin properties | |
CN103816295B (en) | Formula and preparation method for health-maintaining line incense | |
CN103007104A (en) | Compound Chinese mugwort essential oil | |
CN110403869A (en) | A kind of plant is releived composite essential oil and preparation method thereof | |
CN106137801A (en) | A kind of plants essential oil balsam and preparation method thereof | |
KR20070112935A (en) | Herb medicine composition and the method manufacture thereof | |
CN104984275A (en) | Foot bath health-care traditional Chinese medicine benefiting Qi and activating blood | |
CN103925774A (en) | Drying method capable of fully exerting health care function of redwood furniture | |
CN104288821A (en) | Smoke-free incense suitable for use in closed room, and preparation method thereof | |
JP2021091684A (en) | Plant extract composition and method for preparing the same | |
CN106668294A (en) | Salvia miltiorrhiza leaf composite healthcare tea having efficacies for reducing blood glucose, reducing blood fat and lowering blood pressure and preparation method and use of salvia miltiorrhiza composite leaf healthcare tea | |
KR20090037179A (en) | Mixed flower-flavored green tea with excellent preference and preparing method thereof | |
KR100289111B1 (en) | Process for lowering nicotine contents in tobacco | |
CN107594762A (en) | A kind of processing method for preventing and treating beriberi insoles | |
KR101715076B1 (en) | method of manufacturing and Functional shampoo a main material for A.gramineus | |
KR100839663B1 (en) | A cylindrical moxa cautery bar for assiting medical treatment of otorhinolaryngological disease and a preparation method thereof | |
KR20120085219A (en) | Method for making the black polygonatum officinale | |
KR20100020700A (en) | Moxa and manufacturing method thereof | |
KR20060022214A (en) | Manufacturing method of combustion and bath material of moxibustion and incense using lead | |
CN104739952A (en) | Compound tea tree essential oil with effect of promoting wound healing | |
CN104431085A (en) | Tea mixed with tea tree roots and preparation method of tea | |
CN108888700A (en) | A kind of ointment and preparation method thereof | |
KR20040001513A (en) | Deodorizing agent composition for removing and treating bad smell from human body, and deodorizing agent produced therefrom | |
CN104274856A (en) | Incense for improving haze air and preparation method thereof | |
CN109157637A (en) | A kind of children's medicine moxibustion item and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20201208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210224 |
|
AA79 | Non-delivery of priority document |
Free format text: JAPANESE INTERMEDIATE CODE: A24379 Effective date: 20210414 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211203 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220622 |